CLINICAL ASPECTS OF BLOOD PRESSURE CRISIS DUE TO WITHDRAWAL OF CENTRALLY ACTING ANTIHYPERTENSIVE DRUGS
Open Access
- 1 December 1983
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 15 (Supplement), 485S-489S
- https://doi.org/10.1111/j.1365-2125.1983.tb00315.x
Abstract
1 Sudden cessation of antihypertensive therapy, in particular centrally acting drugs such as clonidine, may cause a withdrawal syndrome characterised by a rapid increase in blood pressure, headaches, tremor, restlessness and nausea. 2 The withdrawal syndrome is associated with a marked increase in sympathetic activity, as indicated by the increased levels of urinary and plasma catecholamines. 3 The clonidine withdrawal syndrome is reproducible. 4 The crisis can be managed acutely either by reinstituting the drug which has been withdrawn or by giving α- and β-adrenoceptor blocking drugs, either separately or in the form of labetalol. 5 The withdrawal syndrome can now be reproduced in animal models, but in spite of extensive studies, the exact underlying mechanism remains to be elucidated.Keywords
This publication has 17 references indexed in Scilit:
- Morphine suppresses the blood pressure responses to clonidine withdrawal in the spontaneously hypertensive ratEuropean Journal of Pharmacology, 1981
- Abrupt cessation of clonidine administration: A prospective studyThe American Journal of Cardiology, 1978
- CLONIDINE WITHDRAWAL IN HYPERTENSIONThe Lancet, 1977
- Blood pressure and heart rate and withdrawal of antihypertensive drugs.BMJ, 1977
- WITHDRAWAL OF ANTIHYPERTENSIVE THERAPYThe Lancet, 1974
- Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute managementAmerican Heart Journal, 1973
- Prolonged treatment with clonidine: Comparative antihypertensive effects alone and with a diuretic agentThe American Journal of Cardiology, 1972
- Clonidine hydrochloride in the treatment of hypertensionThe American Journal of Cardiology, 1971
- Studies on catecholamines, renin and aldosterone following catapresan® (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patientsEuropean Journal of Pharmacology, 1970